Thu May 9 10:16:35 2024
EVENTS
 FREE
SOFTWARE
INSTITUTE
 POLITICS
 JOBS
 MEMBERS'
CORNER
 MAILING
LIST
NYLXS Mailing Lists and Archives
NYLXS Members have a lot to say and share but we don't keep many secrets. Join the Hangout Mailing List and say your peice.

DATE 2022-01-01

HANGOUT

2024-05-09 | 2024-04-09 | 2024-03-09 | 2024-02-09 | 2024-01-09 | 2023-12-09 | 2023-11-09 | 2023-10-09 | 2023-09-09 | 2023-08-09 | 2023-07-09 | 2023-06-09 | 2023-05-09 | 2023-04-09 | 2023-03-09 | 2023-02-09 | 2023-01-09 | 2022-12-09 | 2022-11-09 | 2022-10-09 | 2022-09-09 | 2022-08-09 | 2022-07-09 | 2022-06-09 | 2022-05-09 | 2022-04-09 | 2022-03-09 | 2022-02-09 | 2022-01-09 | 2021-12-09 | 2021-11-09 | 2021-10-09 | 2021-09-09 | 2021-08-09 | 2021-07-09 | 2021-06-09 | 2021-05-09 | 2021-04-09 | 2021-03-09 | 2021-02-09 | 2021-01-09 | 2020-12-09 | 2020-11-09 | 2020-10-09 | 2020-09-09 | 2020-08-09 | 2020-07-09 | 2020-06-09 | 2020-05-09 | 2020-04-09 | 2020-03-09 | 2020-02-09 | 2020-01-09 | 2019-12-09 | 2019-11-09 | 2019-10-09 | 2019-09-09 | 2019-08-09 | 2019-07-09 | 2019-06-09 | 2019-05-09 | 2019-04-09 | 2019-03-09 | 2019-02-09 | 2019-01-09 | 2018-12-09 | 2018-11-09 | 2018-10-09 | 2018-09-09 | 2018-08-09 | 2018-07-09 | 2018-06-09 | 2018-05-09 | 2018-04-09 | 2018-03-09 | 2018-02-09 | 2018-01-09 | 2017-12-09 | 2017-11-09 | 2017-10-09 | 2017-09-09 | 2017-08-09 | 2017-07-09 | 2017-06-09 | 2017-05-09 | 2017-04-09 | 2017-03-09 | 2017-02-09 | 2017-01-09 | 2016-12-09 | 2016-11-09 | 2016-10-09 | 2016-09-09 | 2016-08-09 | 2016-07-09 | 2016-06-09 | 2016-05-09 | 2016-04-09 | 2016-03-09 | 2016-02-09 | 2016-01-09 | 2015-12-09 | 2015-11-09 | 2015-10-09 | 2015-09-09 | 2015-08-09 | 2015-07-09 | 2015-06-09 | 2015-05-09 | 2015-04-09 | 2015-03-09 | 2015-02-09 | 2015-01-09 | 2014-12-09 | 2014-11-09 | 2014-10-09 | 2014-09-09 | 2014-08-09 | 2014-07-09 | 2014-06-09 | 2014-05-09 | 2014-04-09 | 2014-03-09 | 2014-02-09 | 2014-01-09 | 2013-12-09 | 2013-11-09 | 2013-10-09 | 2013-09-09 | 2013-08-09 | 2013-07-09 | 2013-06-09 | 2013-05-09 | 2013-04-09 | 2013-03-09 | 2013-02-09 | 2013-01-09 | 2012-12-09 | 2012-11-09 | 2012-10-09 | 2012-09-09 | 2012-08-09 | 2012-07-09 | 2012-06-09 | 2012-05-09 | 2012-04-09 | 2012-03-09 | 2012-02-09 | 2012-01-09 | 2011-12-09 | 2011-11-09 | 2011-10-09 | 2011-09-09 | 2011-08-09 | 2011-07-09 | 2011-06-09 | 2011-05-09 | 2011-04-09 | 2011-03-09 | 2011-02-09 | 2011-01-09 | 2010-12-09 | 2010-11-09 | 2010-10-09 | 2010-09-09 | 2010-08-09 | 2010-07-09 | 2010-06-09 | 2010-05-09 | 2010-04-09 | 2010-03-09 | 2010-02-09 | 2010-01-09 | 2009-12-09 | 2009-11-09 | 2009-10-09 | 2009-09-09 | 2009-08-09 | 2009-07-09 | 2009-06-09 | 2009-05-09 | 2009-04-09 | 2009-03-09 | 2009-02-09 | 2009-01-09 | 2008-12-09 | 2008-11-09 | 2008-10-09 | 2008-09-09 | 2008-08-09 | 2008-07-09 | 2008-06-09 | 2008-05-09 | 2008-04-09 | 2008-03-09 | 2008-02-09 | 2008-01-09 | 2007-12-09 | 2007-11-09 | 2007-10-09 | 2007-09-09 | 2007-08-09 | 2007-07-09 | 2007-06-09 | 2007-05-09 | 2007-04-09 | 2007-03-09 | 2007-02-09 | 2007-01-09 | 2006-12-09 | 2006-11-09 | 2006-10-09 | 2006-09-09 | 2006-08-09 | 2006-07-09 | 2006-06-09 | 2006-05-09 | 2006-04-09 | 2006-03-09 | 2006-02-09 | 2006-01-09 | 2005-12-09 | 2005-11-09 | 2005-10-09 | 2005-09-09 | 2005-08-09 | 2005-07-09 | 2005-06-09 | 2005-05-09 | 2005-04-09 | 2005-03-09 | 2005-02-09 | 2005-01-09 | 2004-12-09 | 2004-11-09 | 2004-10-09 | 2004-09-09 | 2004-08-09 | 2004-07-09 | 2004-06-09 | 2004-05-09 | 2004-04-09 | 2004-03-09 | 2004-02-09 | 2004-01-09 | 2003-12-09 | 2003-11-09 | 2003-10-09 | 2003-09-09 | 2003-08-09 | 2003-07-09 | 2003-06-09 | 2003-05-09 | 2003-04-09 | 2003-03-09 | 2003-02-09 | 2003-01-09 | 2002-12-09 | 2002-11-09 | 2002-10-09 | 2002-09-09 | 2002-08-09 | 2002-07-09 | 2002-06-09 | 2002-05-09 | 2002-04-09 | 2002-03-09 | 2002-02-09 | 2002-01-09 | 2001-12-09 | 2001-11-09 | 2001-10-09 | 2001-09-09 | 2001-08-09 | 2001-07-09 | 2001-06-09 | 2001-05-09 | 2001-04-09 | 2001-03-09 | 2001-02-09 | 2001-01-09 | 2000-12-09 | 2000-11-09 | 2000-10-09 | 2000-09-09 | 2000-08-09 | 2000-07-09 | 2000-06-09 | 2000-05-09 | 2000-04-09 | 2000-03-09 | 2000-02-09 | 2000-01-09 | 1999-12-09

Key: Value:

Key: Value:

MESSAGE
DATE 2022-01-06
FROM IEEE Engineering in Medicine and Biology Society
SUBJECT Subject: [Hangout - NYLXS] Call for Papers - 9th IEEE RAS/EMBS International
From hangout-bounces-at-nylxs.com Thu Jan 6 16:04:28 2022
Return-Path:
X-Original-To: archive-at-mrbrklyn.com
Delivered-To: archive-at-mrbrklyn.com
Received: from www2.mrbrklyn.com (www2.mrbrklyn.com [96.57.23.82])
by mrbrklyn.com (Postfix) with ESMTP id CC7FC163FD0;
Thu, 6 Jan 2022 16:04:22 -0500 (EST)
X-Original-To: hangout-at-www2.mrbrklyn.com
Delivered-To: hangout-at-www2.mrbrklyn.com
Received: by mrbrklyn.com (Postfix, from userid 1000)
id D7823163FB3; Thu, 6 Jan 2022 16:04:15 -0500 (EST)
Resent-From: Ruben Safir
Resent-Date: Thu, 6 Jan 2022 16:04:15 -0500
Resent-Message-ID: <20220106210415.GA14854-at-www2.mrbrklyn.com>
Resent-To: hangout-at-mrbrklyn.com
X-Original-To: ruben-at-mrbrklyn.com
Delivered-To: ruben-at-mrbrklyn.com
Received: from ccm197.constantcontact.com (ccm197.constantcontact.com
[208.75.123.197])
(using TLSv1.2 with cipher ECDHE-RSA-AES256-GCM-SHA384 (256/256 bits))
(Client did not present a certificate)
by mrbrklyn.com (Postfix) with ESMTPS id 2D19C163FA8
for ; Thu, 6 Jan 2022 16:01:24 -0500 (EST)
Received: from [10.252.0.89] ([10.252.0.89:54224]
helo=p2-jbemailsyndicator33.ctct.net) by 10.249.249.10 (envelope-from
)
(ecelerity 4.3.1.69340 r(Core:4.3.1.0)) with ESMTP
id 63/3E-52208-3A857D16; Thu, 06 Jan 2022 16:01:23 -0500
DKIM-Signature: v=1; q=dns/txt; a=rsa-sha256; c=relaxed/relaxed; s=223472;
d=embs.ccsend.com;
h=date:mime-version:subject:X-Feedback-ID:X-250ok-CID:message-id:from:reply-to:list-unsubscribe:list-unsubscribe-post:to;
bh=D43jt9oxoGR1/9z9nppmA1cBw/33tWRb1W7shoxJQXU=;
b=FPeknlPo5sOLGBRlWqR4lO6+OOe6X0P5HfuGZTOku4ALBfbj0M61Q9wDHZD2p89J0Z82bz3y/sNBuFem6OP3rlZts2gZn8OZCPWwD9UuNdSuoxVUUJlEXxzeqqe+y6F8RiUurrug6TsVM5U8GcuUqWnFwkfolM8mSDPndBrPUTY=
DKIM-Signature: v=1; q=dns/txt; a=rsa-sha256; c=relaxed/relaxed; s=1000073432;
d=auth.ccsend.com;
h=date:mime-version:subject:X-Feedback-ID:X-250ok-CID:message-id:from:reply-to:list-unsubscribe:list-unsubscribe-post:to;
bh=D43jt9oxoGR1/9z9nppmA1cBw/33tWRb1W7shoxJQXU=;
b=PqxzAy1UQ2FkaXjQICHpmM5avgLbN2QV4cAzJv/KWTjXf4WNGjviQAxpRKhWLXbeS26jcPYWKIAoI7wAQTzI9vMr1MXWhjyfJgMRXpu1GSjcqyqlQTpqSHmE6RYjQZqUzmCt99PvxcoophP6HwtQt7Xpl2tjH5hBFghOadW+DIQ=
Message-ID: <1138429186072.1101850439430.1404155102.0.311600JL.2002-at-scheduler.constantcontact.com>
Date: Thu, 6 Jan 2022 16:01:23 -0500 (EST)
From: IEEE Engineering in Medicine and Biology Society
To: ruben-at-mrbrklyn.com
MIME-Version: 1.0
List-Unsubscribe-Post: List-Unsubscribe=One-Click
X-Campaign-Activity-ID: 73b2a25c-f182-48fa-b528-cbc0b1894666
X-250ok-CID: 73b2a25c-f182-48fa-b528-cbc0b1894666
X-Channel-ID: cfd83e20-b05d-11e4-8806-d4ae529a8250
X-Mailer: Roving Constant Contact 2012 (http://www.constantcontact.com)
X-Return-Path-Hint: Ac7KiXPGCSPq1KMvAsYlGZg==_1101850439430_z9g+ILBdEeSIBtSuUpqCUA==-at-in.constantcontact.com
X-Roving-Campaignid: 1138429186072
X-Roving-Id: 1101850439430.1404155102
X-Feedback-ID: cfd83e20-b05d-11e4-8806-d4ae529a8250:73b2a25c-f182-48fa-b528-cbc0b1894666:1101850439430:CTCT
X-CTCT-ID: cfcc3030-b05d-11e4-87e7-d4ae529a8250
Subject: [Hangout - NYLXS] Call for Papers - 9th IEEE RAS/EMBS International
Conference on Biomedical Robotics & Biomechatronics
X-BeenThere: hangout-at-nylxs.com
X-Mailman-Version: 2.1.30rc1
Precedence: list
List-Id: NYLXS Tech Talk and Politics
List-Unsubscribe: ,

List-Archive:
List-Post:
List-Help:
List-Subscribe: ,

Reply-To: noreply-at-embs.org
Content-Type: multipart/mixed; boundary="===============1742927418=="
Errors-To: hangout-bounces-at-nylxs.com
Sender: "Hangout"

--===============1742927418==
Content-Type: multipart/alternative;
boundary="----=_Part_62521646_1555497516.1641502883708"

------=_Part_62521646_1555497516.1641502883708
Content-Type: text/plain; charset=utf-8
Content-Transfer-Encoding: quoted-printable

Call for Papers - 9th IEEE RAS/EMBS International Conference on Biomedical =
Robotics & Biomechatronics http://biorob2022.org/ On behalf of the Organizi=
ng Committee, we cordially invite you to submit your work to the 9th IEEE R=
AS/EMBS International Conference on Biomedical Robotics & Biomechatronics (=
BioRob 2022), which will be held in Global Engineering Training Center at S=
eoul National University, Seoul. BioRob2022 is a joint effort of the two =
IEEE Societies of Robotics and Automation =E2=80=93 RAS =E2=80=93 and Engin=
eering in Medicine and Biology =E2=80=93 EMBS. The conference covers both t=
heoretical and experimental challenges posed by the application of robotics=
and mechatronics in medicine and biology. The primary focus of Biorobotics=
is to analyze biological systems from a =E2=80=9Cbiomechatronic=E2=80=9D p=
oint of view, trying to understand the scientific and engineering principle=
s underlying their extraordinary performance. This profound understanding o=
f how biological systems work, behave and interact can be used for two main=
objectives: to guide the design and fabrication of novel, high performance=
bio-inspired machines and systems for many different applications; and to =
develop novel nano-, micro-, and macro-devices that can act upon, substitut=
e parts of, and assist human beings in prevention, diagnosis, surgery, pros=
thetics, rehabilitation and personal assistance. Prospective authors are =
invited to submit high-quality papers presenting original results. The tech=
nical program will consist of plenary sessions, contributed paper sessions,=
workshops and tutorials, contributed posters. Submitted papers will be e=
ligible to be dual-published at the IEEE Robotics and Automation Letters (R=
A-L). Contributions submitted to RA-L / BioRob will go through a separate p=
rocess. Topics of Interest: - Robotics and Rehabilitation - Biologically =
Inspired Robotics - Robotic Surgery - Human Machine Interaction - Wearable =
Technologies - Brain Machine Interface - Robotics in Ageing - Robotic Compa=
nions and Home Care - Human Augmentation - Micro Robotics - Nano Robotics =
Submission link will be available soon at: https://ras.papercept.net/ Impo=
rtant Dates: RA-L BioRob 2022 Submission Deadline Jan.31 Feb.4 Decision of =
Acceptance May 1 April 29 Final Version Deadline May 15 June 3 *Contributio=
ns submitted to RA-L / BioRob will go through a separate process. I=
EEE Engineering in Medicine and Biology Society | 445 Hoes Lane, Piscataway=
, NJ 08854 Unsubscribe ruben-at-mrbrklyn.com Update Profile | About Constant C=
ontact Sent by noreply-at-embs.org in collaboration with Try email marketing f=
or free today!
------=_Part_62521646_1555497516.1641502883708
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: quoted-printable


text/html; charset=3Dutf-8"> ice-width, initial-scale=3D1, maximum-scale=3D1">
=3D"1.9.0" data-canonical-name=3D"CPE-PT16904" align=3D"center" style=3D"-m=
s-text-size-adjust: 100%; -webkit-text-size-adjust: 100%; min-width: 100%; =
width: 100%; margin: 0px; padding: 0px;">
lor: transparent; display: none; font-size: 1px; line-height: 1px; max-heig=
ht: 0px; max-width: 0px; opacity: 0; overflow: hidden;">ef=3D"preheader">Call for Papers - 9th IEEE RAS/EMBS International Con=
ference on Biomedical Robotics & Biomechatronics
=3D"tracking-image" style=3D"color: transparent; display: none; font-size: =
1px; line-height: 1px; max-height: 0px; max-width: 0px; opacity: 0; overflo=
w: hidden;">b528-cbc0b1894666&a=3D1101850439430&c=3Dcfcc3030-b05d-11e4-87e7-d4ae529a825=
0&ch=3Dcfd83e20-b05d-11e4-8806-d4ae529a8250" / alt=3D"">
=3D"shell" lang=3D"en-US" style=3D"background-color: #d0ecf2;"> ss=3D"shell_panel-row" width=3D"100%" border=3D"0" cellpadding=3D"0" cellsp=
acing=3D"0" style=3D"background-color: #d0ecf2;" bgcolor=3D"#d0ecf2"> =
<=
/tr>
=
nter" border=3D"0" cellpadding=3D"0" cellspacing=3D"0">
hell_width-cell" style=3D"padding: 15px 10px;" align=3D"center" valign=3D"t=
op"> border=3D"0" cellpadding=3D"0" cellspacing=3D"0">
ontent-cell" style=3D"background-color: #ffffff; padding: 0;" align=3D"cent=
er" valign=3D"top" bgcolor=3D"#ffffff"> lumn" style=3D"background-color: #d4edfb; table-layout: fixed;" width=3D"10=
0%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0" bgcolor=3D"#d4edfb"> <=
tr>
ign=3D"center" valign=3D"top">
border=3D"0">
: 30px; height: 1px; line-height: 1px;" width=3D"100%" align=3D"center" val=
ign=3D"top"> 3D""0" vspace=3D"0" src=3D"https://imgssl.constantcontact.com/letters/images/11=
01116784221/S.gif" style=3D"display: block; height: 1px; width: 5px;"> >
nter" width=3D"100%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0"> =
mage-content class=3D"image_content" width=3D"580" src=3D"https://files.con=
stantcontact.com/60f676b8001/e17addd2-898b-43e4-aa8b-a12ac9dc10d9.png" alt=
=3D"Blue Header Constant Contact.png" style=3D"display: block; height: auto=
; max-width: 100%;">
=3D"layout layout--1-column" style=3D"table-layout: fixed;" width=3D"100%" =
border=3D"0" cellpadding=3D"0" cellspacing=3D"0">
column--1 scale stack" style=3D"" width=3D"100%" align=3D"center" valign=3D=
"top">
=3D"table-layout: fixed;" width=3D"100%" border=3D"0" cellpadding=3D"0" cel=
lspacing=3D"0">
width=3D"100%" align=3D"center" valign=3D"top">
bile-center" width=3D"100%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0=
"> =
enter" valign=3D"top" style=3D"padding: 10px 50px;"> t class=3D"image_content" width=3D"580" src=3D"https://files.constantcontac=
t.com/60f676b8001/010842bd-10a0-4bce-b922-da881d394160.png" alt=3D"main_txt=
.png" style=3D"display: block; height: auto; max-width: 100%;">
le=3D"table-layout: fixed;" width=3D"100%" border=3D"0" cellpadding=3D"0" c=
ellspacing=3D"0">
" width=3D"100%" align=3D"center" valign=3D"top">
llpadding=3D"0" cellspacing=3D"0" style=3D"table-layout: fixed;">
class=3D"text_content-cell content-padding-horizontal" style=3D"text-align:=
left; font-family: Arial,Verdana,Helvetica,sans-serif; color: #2f2f2f; fon=
t-size: 16px; line-height: 1.2; display: block; word-wrap: break-word; padd=
ing: 10px 50px;" align=3D"left" valign=3D"top">

ref=3D"https://r20.rs6.net/tn.jsp?f=3D001ZZriHBrpHq0Q9fqa4sFpOP2Bp_yL0bAjpa=
X92MCohLagWY48_VLBA2R_PoSc___HNXoGbQYxP7mUbNSXYpOZniNd_edjXkZ6sx74mIQp7sIWf=
3HK2Fdfex10bHatkQpf9r6ozN3_Zug=3D&c=3DfsvHkqyFmkj6BCB4YuRDh_97icrfTAzjK_IEo=
JV_CAbZRndzjrihXA=3D=3D&ch=3DfnlNFU0m1Qq2acsA15dIHfBzjO2FekgkD8tOgogsWiIXtb=
q-dgOXwg=3D=3D" target=3D"_blank" style=3D"font-size: 13px; color: rgb(17, =
85, 204); font-weight: bold; text-decoration: none;">http://biorob2022.org/=
yout--1-column" style=3D"table-layout: fixed;" width=3D"100%" border=3D"0" =
cellpadding=3D"0" cellspacing=3D"0">
le stack" style=3D"" width=3D"100%" align=3D"center" valign=3D"top">
llpadding=3D"0" cellspacing=3D"0" style=3D"table-layout: fixed;">
class=3D"text_content-cell content-padding-horizontal" style=3D"text-align:=
left; font-family: Arial,Verdana,Helvetica,sans-serif; color: #2f2f2f; fon=
t-size: 16px; line-height: 1.2; display: block; word-wrap: break-word; padd=
ing: 10px 50px;" align=3D"left" valign=3D"top">

On behalf of the O=
rganizing Committee, we cordially invite you to submit your work to the 9th=
IEEE RAS/EMBS International Conference on Biomedical Robotics & Biomec=
hatronics (BioRob 2022), which will be held in Global Engineering Training =
Center at Seoul National University, Seoul.


 


BioRob2022 is a jo=
int effort of the two IEEE Societies of Robotics and Automation – RA=
S – and Engineering in Medicine and Biology – EMBS. The confe=
rence covers both theoretical and experimental challenges posed by the appl=
ication of robotics and mechatronics in medicine and biology. The primary f=
ocus of Biorobotics is to analyze biological systems from a “biomech=
atronic” point of view, trying to understand the scientific and engi=
neering principles underlying their extraordinary performance. This profoun=
d understanding of how biological systems work, behave and interact can be =
used for two main objectives: to guide the design and fabrication of novel,=
high performance bio-inspired machines and systems for many different appl=
ications; and to develop novel nano-, micro-, and macro-devices that can ac=
t upon, substitute parts of, and assist human beings in prevention, diagnos=
is, surgery, prosthetics, rehabilitation and personal


assistance.=


 


Prospective author=
s are invited to submit high-quality papers presenting original results. Th=
e technical program will consist of plenary sessions, contributed paper ses=
sions, workshops and tutorials, contributed posters.


 


Submitted papers w=
ill be eligible to be dual-published at the IEEE Robotics and Automation Le=
tters (RA-L). Contributions submitted to RA-L / BioRob will go through a se=
parate process.


 


Topics of Interest=
:


- Robotics and Reh=
abilitation


- Biologically Ins=
pired Robotics


- Robotic Surgery<=
/span>


- Human Machine In=
teraction


- Wearable Technol=
ogies


- Brain Machine In=
terface


- Robotics in Agei=
ng


- Robotic Companio=
ns and Home Care


- Human Augmentati=
on


- Micro Roboticsspan>


- Nano Roboticspan>


 


Submission link wi=
ll be available soon at:


rpHq0Q9fqa4sFpOP2Bp_yL0bAjpaX92MCohLagWY48_VLBA2R_PoSc___HnYDnSlh6AWuNuQJlU=
bo8JaVJ4C3_tCaqGBou0ocIA-Os8wKtyNHnf4N5gu60287ch3U0vK_eMeWAxrD4-X2XiA=3D=3D=
&c=3DfsvHkqyFmkj6BCB4YuRDh_97icrfTAzjK_IEoJV_CAbZRndzjrihXA=3D=3D&ch=3DfnlN=
FU0m1Qq2acsA15dIHfBzjO2FekgkD8tOgogsWiIXtbq-dgOXwg=3D=3D" target=3D"_blank"=
style=3D"font-size: 13px; color: rgb(17, 85, 204); font-weight: bold; text=
-decoration: none;">https://ras.papercept.net/ 13px; color: rgb(17, 85, 204);">


column" style=3D"table-layout: fixed;" width=3D"100%" border=3D"0" cellpadd=
ing=3D"0" cellspacing=3D"0">
" style=3D"" width=3D"100%" align=3D"center" valign=3D"top">
border=3D"0">
al" style=3D"padding: 10px 50px;" width=3D"100%" align=3D"center" valign=3D=
"top"> 0%;" cellpadding=3D"0" cellspacing=3D"0" border=3D"0">
vider_content-cell" style=3D"height: 1px; line-height: 1px; padding-bottom:=
0px; background-color: #403F42; border-bottom-width: 0px;" height=3D"1" al=
ign=3D"center" bgcolor=3D"#403F42"> 3D""border=3D"0" hspace=3D"0" vspace=3D"0" src=3D"https://imgssl.constantcontac=
t.com/letters/images/1101116784221/S.gif" style=3D"display: block; height: =
1px; width: 5px;">
=3D"text text--padding-vertical" width=3D"100%" border=3D"0" cellpadding=3D=
"0" cellspacing=3D"0" style=3D"table-layout: fixed;"> =
t_content-cell content-padding-horizontal" style=3D"text-align: left; font-=
family: Arial,Verdana,Helvetica,sans-serif; color: #2f2f2f; font-size: 16px=
; line-height: 1.2; display: block; word-wrap: break-word; padding: 10px 50=
px;" align=3D"left" valign=3D"top">

ont-size: 13px; font-weight: bold;">Important Dates:
e=3D"table-layout: fixed;" width=3D"100%" border=3D"0" cellpadding=3D"0" ce=
llspacing=3D"0">
width=3D"100%" align=3D"center" valign=3D"top">
border=3D"0" cellpadding=3D"0" cellspacing=3D"0" style=3D"table-layout: fi=
xed;"> =
e=3D"text-align: left; font-family: Arial,Verdana,Helvetica,sans-serif; col=
or: #2f2f2f; font-size: 16px; line-height: 1.2; display: block; word-wrap: =
break-word; padding: 10px 50px;" align=3D"left" valign=3D"top" data-purpose=
=3D"dataTable">
nerBorder"> dth: 100%; background-color: #ffffff; border: 1px solid #979797;" width=3D"=
100%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0" bgcolor=3D"#ffffff">=
r>
ertical-align: top; font-size: 14px; padding: 10px; border: 1px solid #9797=
97;" align=3D"center" valign=3D"top">


> 		al-align: top; font-size: 14px; padding: 10px; border: 1px solid #979797;" =
align=3D"center" valign=3D"top">

t-size: 13px;">RA-L

 style=3D"text-align: center; vertical-align: top; font-size: 14px; padding:=
10px; border: 1px solid #979797;" align=3D"center" valign=3D"top">

e=3D"margin: 0;">BioRob 2022

td>
center; vertical-align: top; font-size: 14px; padding: 10px; border: 1px s=
olid #979797;" align=3D"center" valign=3D"top">

an style=3D"font-size: 13px;">Submission Deadline

 ss=3D"dataTable_content-cell" style=3D"text-align: center; vertical-align: =
top; font-size: 14px; padding: 10px; border: 1px solid #979797;" align=3D"c=
enter" valign=3D"top">

px;">Jan.31

 "text-align: center; vertical-align: top; font-size: 14px; padding: 10px; b=
order: 1px solid #979797;" align=3D"center" valign=3D"top">

gin: 0;">Feb.4
cal-align: top; font-size: 14px; padding: 10px; border: 1px solid #979797;"=
align=3D"center" valign=3D"top">

nt-size: 13px;">Decision of Acceptance

 able_content-cell" style=3D"text-align: center; vertical-align: top; font-s=
ize: 14px; padding: 10px; border: 1px solid #979797;" align=3D"center" vali=
gn=3D"top">

May 1<=
/span>

 center; vertical-align: top; font-size: 14px; padding: 10px; border: 1px s=
olid #979797;" align=3D"center" valign=3D"top">

an style=3D"font-size: 13px;">April 29
lass=3D"dataTable_content-cell" style=3D"text-align: center; vertical-align=
: top; font-size: 14px; padding: 10px; border: 1px solid #979797;" align=3D=
"center" valign=3D"top">

13px;">Final Version Deadline

 ent-cell" style=3D"text-align: center; vertical-align: top; font-size: 14px=
; padding: 10px; border: 1px solid #979797;" align=3D"center" valign=3D"top=
">

May 15p>

vertical-align: top; font-size: 14px; padding: 10px; border: 1px solid #97=
9797;" align=3D"center" valign=3D"top">

=3D"font-size: 13px;">June 3
" style=3D"table-layout: fixed;" width=3D"100%" border=3D"0" cellpadding=3D=
"0" cellspacing=3D"0"> =
e=3D"" width=3D"100%" align=3D"center" valign=3D"top">
llpadding=3D"0" cellspacing=3D"0" style=3D"table-layout: fixed;">
class=3D"text_content-cell content-padding-horizontal" style=3D"text-align:=
left; font-family: Arial,Verdana,Helvetica,sans-serif; color: #2f2f2f; fon=
t-size: 16px; line-height: 1.2; display: block; word-wrap: break-word; padd=
ing: 10px 50px;" align=3D"left" valign=3D"top">

n style=3D"font-size: 13px;">*Contributions submitted to RA-L / BioRob will=
go through a separate process.
xed;" width=3D"100%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0"> =
table>
=3D"center" valign=3D"top">
border=3D"0">
al" style=3D"padding: 10px 50px;" width=3D"100%" align=3D"center" valign=3D=
"top"> 0%;" cellpadding=3D"0" cellspacing=3D"0" border=3D"0">
vider_content-cell" style=3D"height: 1px; line-height: 1px; padding-bottom:=
0px; background-color: #403F42; border-bottom-width: 0px;" height=3D"1" al=
ign=3D"center" bgcolor=3D"#403F42"> 3D""border=3D"0" hspace=3D"0" vspace=3D"0" src=3D"https://imgssl.constantcontac=
t.com/letters/images/1101116784221/S.gif" style=3D"display: block; height: =
1px; width: 5px;">
d;" width=3D"100%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0"> <=
td class=3D"column column--1 scale stack" style=3D"" width=3D"100%" align=
=3D"center" valign=3D"top">
cellpadding=3D"0" cellspacing=3D"0" border=3D"0">
Follow_container" width=3D"100%" align=3D"center" valign=3D"top" style=3D"p=
adding-top: 10px; padding-bottom: 10px; height: 1px; line-height: 1px;"> href=3D"https://r20.rs6.net/tn.jsp?f=3D001ZZriHBrpHq0Q9fqa4sFpOP2Bp_yL0bAj=
paX92MCohLagWY48_VLBA7srVKOEggyBjH4Ox80ixYR2YipZbZT8M6HdHecWeXXZLp6ucY049X-=
vhGRfBe3ItI4f79vz3x7xDr37EEyvGm7w0mr9wG1BkPqs7Lftmsdw&c=3DfsvHkqyFmkj6BCB4Y=
uRDh_97icrfTAzjK_IEoJV_CAbZRndzjrihXA=3D=3D&ch=3DfnlNFU0m1Qq2acsA15dIHfBzjO=
2FekgkD8tOgogsWiIXtbq-dgOXwg=3D=3D" data-trackable=3D"true">ocialFollow_icon" alt=3D"Facebook" width=3D"32" border=3D"0" src=3D"https:/=
/imgssl.constantcontact.com/letters/images/CPE/SocialIcons/circles/circleCo=
lor_Facebook.png" style=3D"display: inline-block; margin: 0; padding: 0;"><=
/a>  OP2Bp_yL0bAjpaX92MCohLagWY48_VLBA6HXzj2oHM9fcfIOm-aEWBE0n1Iet65uaQLNNOdx_Ro=
2JJdwEwwmoogv4vNL-yesAgmMTLvkKzJ_CZmgAMAilCXwoH7S_ijnsg=3D=3D&c=3DfsvHkqyFm=
kj6BCB4YuRDh_97icrfTAzjK_IEoJV_CAbZRndzjrihXA=3D=3D&ch=3DfnlNFU0m1Qq2acsA15=
dIHfBzjO2FekgkD8tOgogsWiIXtbq-dgOXwg=3D=3D" data-trackable=3D"true">ass=3D"socialFollow_icon" alt=3D"Twitter" width=3D"32" border=3D"0" src=3D"=
https://imgssl.constantcontact.com/letters/images/CPE/SocialIcons/circles/c=
ircleColor_Twitter.png" style=3D"display: inline-block; margin: 0; padding:=
0;">  qa4sFpOP2Bp_yL0bAjpaX92MCohLagWY48_VLBA8s64CAv9e3CZ84AvZ14eYRkJfbNnaAS2kYJR=
SNbercb1neteM72DLx7aQgdX4aTgpcbhcTUprTomWcS3PspQ71WMYGTlMjJd-Kg9h5KateQ&c=
=3DfsvHkqyFmkj6BCB4YuRDh_97icrfTAzjK_IEoJV_CAbZRndzjrihXA=3D=3D&ch=3DfnlNFU=
0m1Qq2acsA15dIHfBzjO2FekgkD8tOgogsWiIXtbq-dgOXwg=3D=3D" data-trackable=3D"t=
rue">3D"Instagram"=3D"0" src=3D"https://imgssl.constantcontact.com/letters/images/CPE/SocialI=
cons/circles/circleColor_Instagram.png" style=3D"display: inline-block; mar=
gin: 0; padding: 0;">  01ZZriHBrpHq0Q9fqa4sFpOP2Bp_yL0bAjpaX92MCohLagWY48_VLBAzdycEz6Z2qeWks1Z1YSK=
hMdvYk4a3014hZ7li6eCFiX2bu2E8BZOy3BluuLc0_dMkpx0cUWYeE5J54gNBALq4wJucl_E_hM=
lrFjpC-kgfpGBb-145xDVAI=3D&c=3DfsvHkqyFmkj6BCB4YuRDh_97icrfTAzjK_IEoJV_CAbZ=
RndzjrihXA=3D=3D&ch=3DfnlNFU0m1Qq2acsA15dIHfBzjO2FekgkD8tOgogsWiIXtbq-dgOXw=
g=3D=3D" data-trackable=3D"true">3D"Li=<BRnkedIn" width=3D"32" border=3D"0" src=3D"https://imgssl.constantcontact.com=
/letters/images/CPE/SocialIcons/circles/circleColor_LinkedIn.png" style=3D"=
display: inline-block; margin: 0; padding: 0;">  //r20.rs6.net/tn.jsp?f=3D001ZZriHBrpHq0Q9fqa4sFpOP2Bp_yL0bAjpaX92MCohLagWY4=
8_VLBAzdycEz6Z2qefeRTDgvfOHZKB-W4ab54oWEOAIZuiWiRl4c75HrN6qaOH8no9PcDxjFfpP=
LbsiMC4lx1X88OLh7zE84vLGhcgxl7Xq4QYoh6I6s-umEjhpw=3D&c=3DfsvHkqyFmkj6BCB4Yu=
RDh_97icrfTAzjK_IEoJV_CAbZRndzjrihXA=3D=3D&ch=3DfnlNFU0m1Qq2acsA15dIHfBzjO2=
FekgkD8tOgogsWiIXtbq-dgOXwg=3D=3D" data-trackable=3D"true">cialFollow_icon" alt=3D"YouTube" width=3D"32" border=3D"0" src=3D"https://i=
mgssl.constantcontact.com/letters/images/CPE/SocialIcons/circles/circleColo=
r_YouTube.png" style=3D"display: inline-block; margin: 0; padding: 0;">=
ell--systemFooter" style=3D"" align=3D"center" valign=3D"top"> s=3D"shell_width-row scale" style=3D"width: 100%;" align=3D"center" border=
=3D"0" cellpadding=3D"0" cellspacing=3D"0">
ell" style=3D"padding: 0px;" align=3D"center" valign=3D"top"> ss=3D"shell_content-row" width=3D"100%" align=3D"center" border=3D"0" cellp=
adding=3D"0" cellspacing=3D"0">
=3D"background-color: #ffffff; padding: 0;" align=3D"center" valign=3D"top"=
bgcolor=3D"#ffffff"> le-layout: fixed;" width=3D"100%" border=3D"0" cellpadding=3D"0" cellspacin=
g=3D"0">
=3D"100%" align=3D"center" valign=3D"top"> "100%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0" style=3D"font-famil=
y: Verdana,Geneva,sans-serif; color: #5d5d5d; font-size: 12px;">
lass=3D"footer_container" align=3D"center"> r" width=3D"100%" cellpadding=3D"0" cellspacing=3D"0" border=3D"0" style=3D=
"background-color: #ffffff; margin-left: auto; margin-right: auto; table-la=
yout: auto !important;" bgcolor=3D"#ffffff">




auto; margin-right: auto; max-width: 100%;">




g: 16px 0px;">
lpadding=3D"0" cellspacing=3D"0">









5d5d5d; font-family: Verdana,Geneva,sans-serif; font-size: 12px; padding: 4=
px 0px;">
IEEE Engineering in Medicine and Biology Soci=
ety | ter-column">445 Hoes Lane, an>n>Piscataway, NJ 08854ooter-column">
10px 0px;">










5d5d5d; font-family: Verdana,Geneva,sans-serif; font-size: 12px; padding: 4=
px 0px;">
_HxeUABc47Q%3D&ch=3Dcfd83e20-b05d-11e4-8806-d4ae529a8250&ca=3D73b2a25c-f182=
-48fa-b528-cbc0b1894666" style=3D"color: #5d5d5d;">Unsubscribe ruben-at-mrbrkl=
yn.com
5d5d5d; font-family: Verdana,Geneva,sans-serif; font-size: 12px; padding: 4=
px 0px;">
_HxeUABc47Q%3D&ch=3Dcfd83e20-b05d-11e4-8806-d4ae529a8250&ca=3D73b2a25c-f182=
-48fa-b528-cbc0b1894666" style=3D"color: #5d5d5d;">Update Profile |
egal/about-constant-contact" style=3D"color: #5d5d5d;">About Constant Conta=
ct
5d5d5d; font-family: Verdana,Geneva,sans-serif; font-size: 12px; padding: 4=
px 0px;">
Sent by
n: none;">noreply-at-embs.org
in collaboration with

5d5d5d; font-family: Verdana,Geneva,sans-serif; font-size: 12px; padding: 4=
px 0px;">








&pn=3DROVING&nav=3D73b2a25c-f182-48fa-b528-cbc0b1894666" style=3D"color: #5=
d5d5d; text-decoration: none;">
3D"Trusted=3D"211" border=3D"0" hspace=3D"0" vspace=3D"0" src=3D"https://imgssl.const=
antcontact.com/ui/images1/logo_ctct_2x.png">
r: #5d5d5d; font-family: Verdana,Geneva,sans-serif; font-size: 9px;">
&pn=3DROVING&nav=3D73b2a25c-f182-48fa-b528-cbc0b1894666" style=3D"color: #5=
d5d5d; text-decoration: none;">Try email marketing for free today!
=


------=_Part_62521646_1555497516.1641502883708--

--===============1742927418==
Content-Type: text/plain; charset="us-ascii"
MIME-Version: 1.0
Content-Transfer-Encoding: 7bit
Content-Disposition: inline

_______________________________________________
Hangout mailing list
Hangout-at-nylxs.com
http://lists.mrbrklyn.com/mailman/listinfo/hangout

--===============1742927418==--

--===============1742927418==
Content-Type: multipart/alternative;
boundary="----=_Part_62521646_1555497516.1641502883708"

------=_Part_62521646_1555497516.1641502883708
Content-Type: text/plain; charset=utf-8
Content-Transfer-Encoding: quoted-printable

Call for Papers - 9th IEEE RAS/EMBS International Conference on Biomedical =
Robotics & Biomechatronics http://biorob2022.org/ On behalf of the Organizi=
ng Committee, we cordially invite you to submit your work to the 9th IEEE R=
AS/EMBS International Conference on Biomedical Robotics & Biomechatronics (=
BioRob 2022), which will be held in Global Engineering Training Center at S=
eoul National University, Seoul. BioRob2022 is a joint effort of the two =
IEEE Societies of Robotics and Automation =E2=80=93 RAS =E2=80=93 and Engin=
eering in Medicine and Biology =E2=80=93 EMBS. The conference covers both t=
heoretical and experimental challenges posed by the application of robotics=
and mechatronics in medicine and biology. The primary focus of Biorobotics=
is to analyze biological systems from a =E2=80=9Cbiomechatronic=E2=80=9D p=
oint of view, trying to understand the scientific and engineering principle=
s underlying their extraordinary performance. This profound understanding o=
f how biological systems work, behave and interact can be used for two main=
objectives: to guide the design and fabrication of novel, high performance=
bio-inspired machines and systems for many different applications; and to =
develop novel nano-, micro-, and macro-devices that can act upon, substitut=
e parts of, and assist human beings in prevention, diagnosis, surgery, pros=
thetics, rehabilitation and personal assistance. Prospective authors are =
invited to submit high-quality papers presenting original results. The tech=
nical program will consist of plenary sessions, contributed paper sessions,=
workshops and tutorials, contributed posters. Submitted papers will be e=
ligible to be dual-published at the IEEE Robotics and Automation Letters (R=
A-L). Contributions submitted to RA-L / BioRob will go through a separate p=
rocess. Topics of Interest: - Robotics and Rehabilitation - Biologically =
Inspired Robotics - Robotic Surgery - Human Machine Interaction - Wearable =
Technologies - Brain Machine Interface - Robotics in Ageing - Robotic Compa=
nions and Home Care - Human Augmentation - Micro Robotics - Nano Robotics =
Submission link will be available soon at: https://ras.papercept.net/ Impo=
rtant Dates: RA-L BioRob 2022 Submission Deadline Jan.31 Feb.4 Decision of =
Acceptance May 1 April 29 Final Version Deadline May 15 June 3 *Contributio=
ns submitted to RA-L / BioRob will go through a separate process. I=
EEE Engineering in Medicine and Biology Society | 445 Hoes Lane, Piscataway=
, NJ 08854 Unsubscribe ruben-at-mrbrklyn.com Update Profile | About Constant C=
ontact Sent by noreply-at-embs.org in collaboration with Try email marketing f=
or free today!
------=_Part_62521646_1555497516.1641502883708
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: quoted-printable


text/html; charset=3Dutf-8"> ice-width, initial-scale=3D1, maximum-scale=3D1">
=3D"1.9.0" data-canonical-name=3D"CPE-PT16904" align=3D"center" style=3D"-m=
s-text-size-adjust: 100%; -webkit-text-size-adjust: 100%; min-width: 100%; =
width: 100%; margin: 0px; padding: 0px;">
lor: transparent; display: none; font-size: 1px; line-height: 1px; max-heig=
ht: 0px; max-width: 0px; opacity: 0; overflow: hidden;">ef=3D"preheader">Call for Papers - 9th IEEE RAS/EMBS International Con=
ference on Biomedical Robotics & Biomechatronics
=3D"tracking-image" style=3D"color: transparent; display: none; font-size: =
1px; line-height: 1px; max-height: 0px; max-width: 0px; opacity: 0; overflo=
w: hidden;">b528-cbc0b1894666&a=3D1101850439430&c=3Dcfcc3030-b05d-11e4-87e7-d4ae529a825=
0&ch=3Dcfd83e20-b05d-11e4-8806-d4ae529a8250" / alt=3D"">
=3D"shell" lang=3D"en-US" style=3D"background-color: #d0ecf2;"> ss=3D"shell_panel-row" width=3D"100%" border=3D"0" cellpadding=3D"0" cellsp=
acing=3D"0" style=3D"background-color: #d0ecf2;" bgcolor=3D"#d0ecf2"> =
<=
/tr>
=
nter" border=3D"0" cellpadding=3D"0" cellspacing=3D"0">
hell_width-cell" style=3D"padding: 15px 10px;" align=3D"center" valign=3D"t=
op"> border=3D"0" cellpadding=3D"0" cellspacing=3D"0">
ontent-cell" style=3D"background-color: #ffffff; padding: 0;" align=3D"cent=
er" valign=3D"top" bgcolor=3D"#ffffff"> lumn" style=3D"background-color: #d4edfb; table-layout: fixed;" width=3D"10=
0%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0" bgcolor=3D"#d4edfb"> <=
tr>
ign=3D"center" valign=3D"top">
border=3D"0">
: 30px; height: 1px; line-height: 1px;" width=3D"100%" align=3D"center" val=
ign=3D"top"> 3D""0" vspace=3D"0" src=3D"https://imgssl.constantcontact.com/letters/images/11=
01116784221/S.gif" style=3D"display: block; height: 1px; width: 5px;"> >
nter" width=3D"100%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0"> =
mage-content class=3D"image_content" width=3D"580" src=3D"https://files.con=
stantcontact.com/60f676b8001/e17addd2-898b-43e4-aa8b-a12ac9dc10d9.png" alt=
=3D"Blue Header Constant Contact.png" style=3D"display: block; height: auto=
; max-width: 100%;">
=3D"layout layout--1-column" style=3D"table-layout: fixed;" width=3D"100%" =
border=3D"0" cellpadding=3D"0" cellspacing=3D"0">
column--1 scale stack" style=3D"" width=3D"100%" align=3D"center" valign=3D=
"top">
=3D"table-layout: fixed;" width=3D"100%" border=3D"0" cellpadding=3D"0" cel=
lspacing=3D"0">
width=3D"100%" align=3D"center" valign=3D"top">
bile-center" width=3D"100%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0=
"> =
enter" valign=3D"top" style=3D"padding: 10px 50px;"> t class=3D"image_content" width=3D"580" src=3D"https://files.constantcontac=
t.com/60f676b8001/010842bd-10a0-4bce-b922-da881d394160.png" alt=3D"main_txt=
.png" style=3D"display: block; height: auto; max-width: 100%;">
le=3D"table-layout: fixed;" width=3D"100%" border=3D"0" cellpadding=3D"0" c=
ellspacing=3D"0">
" width=3D"100%" align=3D"center" valign=3D"top">
llpadding=3D"0" cellspacing=3D"0" style=3D"table-layout: fixed;">
class=3D"text_content-cell content-padding-horizontal" style=3D"text-align:=
left; font-family: Arial,Verdana,Helvetica,sans-serif; color: #2f2f2f; fon=
t-size: 16px; line-height: 1.2; display: block; word-wrap: break-word; padd=
ing: 10px 50px;" align=3D"left" valign=3D"top">

ref=3D"https://r20.rs6.net/tn.jsp?f=3D001ZZriHBrpHq0Q9fqa4sFpOP2Bp_yL0bAjpa=
X92MCohLagWY48_VLBA2R_PoSc___HNXoGbQYxP7mUbNSXYpOZniNd_edjXkZ6sx74mIQp7sIWf=
3HK2Fdfex10bHatkQpf9r6ozN3_Zug=3D&c=3DfsvHkqyFmkj6BCB4YuRDh_97icrfTAzjK_IEo=
JV_CAbZRndzjrihXA=3D=3D&ch=3DfnlNFU0m1Qq2acsA15dIHfBzjO2FekgkD8tOgogsWiIXtb=
q-dgOXwg=3D=3D" target=3D"_blank" style=3D"font-size: 13px; color: rgb(17, =
85, 204); font-weight: bold; text-decoration: none;">http://biorob2022.org/=
yout--1-column" style=3D"table-layout: fixed;" width=3D"100%" border=3D"0" =
cellpadding=3D"0" cellspacing=3D"0">
le stack" style=3D"" width=3D"100%" align=3D"center" valign=3D"top">
llpadding=3D"0" cellspacing=3D"0" style=3D"table-layout: fixed;">
class=3D"text_content-cell content-padding-horizontal" style=3D"text-align:=
left; font-family: Arial,Verdana,Helvetica,sans-serif; color: #2f2f2f; fon=
t-size: 16px; line-height: 1.2; display: block; word-wrap: break-word; padd=
ing: 10px 50px;" align=3D"left" valign=3D"top">

On behalf of the O=
rganizing Committee, we cordially invite you to submit your work to the 9th=
IEEE RAS/EMBS International Conference on Biomedical Robotics & Biomec=
hatronics (BioRob 2022), which will be held in Global Engineering Training =
Center at Seoul National University, Seoul.


 


BioRob2022 is a jo=
int effort of the two IEEE Societies of Robotics and Automation – RA=
S – and Engineering in Medicine and Biology – EMBS. The confe=
rence covers both theoretical and experimental challenges posed by the appl=
ication of robotics and mechatronics in medicine and biology. The primary f=
ocus of Biorobotics is to analyze biological systems from a “biomech=
atronic” point of view, trying to understand the scientific and engi=
neering principles underlying their extraordinary performance. This profoun=
d understanding of how biological systems work, behave and interact can be =
used for two main objectives: to guide the design and fabrication of novel,=
high performance bio-inspired machines and systems for many different appl=
ications; and to develop novel nano-, micro-, and macro-devices that can ac=
t upon, substitute parts of, and assist human beings in prevention, diagnos=
is, surgery, prosthetics, rehabilitation and personal


assistance.=


 


Prospective author=
s are invited to submit high-quality papers presenting original results. Th=
e technical program will consist of plenary sessions, contributed paper ses=
sions, workshops and tutorials, contributed posters.


 


Submitted papers w=
ill be eligible to be dual-published at the IEEE Robotics and Automation Le=
tters (RA-L). Contributions submitted to RA-L / BioRob will go through a se=
parate process.


 


Topics of Interest=
:


- Robotics and Reh=
abilitation


- Biologically Ins=
pired Robotics


- Robotic Surgery<=
/span>


- Human Machine In=
teraction


- Wearable Technol=
ogies


- Brain Machine In=
terface


- Robotics in Agei=
ng


- Robotic Companio=
ns and Home Care


- Human Augmentati=
on


- Micro Roboticsspan>


- Nano Roboticspan>


 


Submission link wi=
ll be available soon at:


rpHq0Q9fqa4sFpOP2Bp_yL0bAjpaX92MCohLagWY48_VLBA2R_PoSc___HnYDnSlh6AWuNuQJlU=
bo8JaVJ4C3_tCaqGBou0ocIA-Os8wKtyNHnf4N5gu60287ch3U0vK_eMeWAxrD4-X2XiA=3D=3D=
&c=3DfsvHkqyFmkj6BCB4YuRDh_97icrfTAzjK_IEoJV_CAbZRndzjrihXA=3D=3D&ch=3DfnlN=
FU0m1Qq2acsA15dIHfBzjO2FekgkD8tOgogsWiIXtbq-dgOXwg=3D=3D" target=3D"_blank"=
style=3D"font-size: 13px; color: rgb(17, 85, 204); font-weight: bold; text=
-decoration: none;">https://ras.papercept.net/ 13px; color: rgb(17, 85, 204);">


column" style=3D"table-layout: fixed;" width=3D"100%" border=3D"0" cellpadd=
ing=3D"0" cellspacing=3D"0">
" style=3D"" width=3D"100%" align=3D"center" valign=3D"top">
border=3D"0">
al" style=3D"padding: 10px 50px;" width=3D"100%" align=3D"center" valign=3D=
"top"> 0%;" cellpadding=3D"0" cellspacing=3D"0" border=3D"0">
vider_content-cell" style=3D"height: 1px; line-height: 1px; padding-bottom:=
0px; background-color: #403F42; border-bottom-width: 0px;" height=3D"1" al=
ign=3D"center" bgcolor=3D"#403F42"> 3D""border=3D"0" hspace=3D"0" vspace=3D"0" src=3D"https://imgssl.constantcontac=
t.com/letters/images/1101116784221/S.gif" style=3D"display: block; height: =
1px; width: 5px;">
=3D"text text--padding-vertical" width=3D"100%" border=3D"0" cellpadding=3D=
"0" cellspacing=3D"0" style=3D"table-layout: fixed;"> =
t_content-cell content-padding-horizontal" style=3D"text-align: left; font-=
family: Arial,Verdana,Helvetica,sans-serif; color: #2f2f2f; font-size: 16px=
; line-height: 1.2; display: block; word-wrap: break-word; padding: 10px 50=
px;" align=3D"left" valign=3D"top">

ont-size: 13px; font-weight: bold;">Important Dates:
e=3D"table-layout: fixed;" width=3D"100%" border=3D"0" cellpadding=3D"0" ce=
llspacing=3D"0">
width=3D"100%" align=3D"center" valign=3D"top">
border=3D"0" cellpadding=3D"0" cellspacing=3D"0" style=3D"table-layout: fi=
xed;"> =
e=3D"text-align: left; font-family: Arial,Verdana,Helvetica,sans-serif; col=
or: #2f2f2f; font-size: 16px; line-height: 1.2; display: block; word-wrap: =
break-word; padding: 10px 50px;" align=3D"left" valign=3D"top" data-purpose=
=3D"dataTable">
nerBorder"> dth: 100%; background-color: #ffffff; border: 1px solid #979797;" width=3D"=
100%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0" bgcolor=3D"#ffffff">=
r>
ertical-align: top; font-size: 14px; padding: 10px; border: 1px solid #9797=
97;" align=3D"center" valign=3D"top">


> 		al-align: top; font-size: 14px; padding: 10px; border: 1px solid #979797;" =
align=3D"center" valign=3D"top">

t-size: 13px;">RA-L

 style=3D"text-align: center; vertical-align: top; font-size: 14px; padding:=
10px; border: 1px solid #979797;" align=3D"center" valign=3D"top">

e=3D"margin: 0;">BioRob 2022

td>
center; vertical-align: top; font-size: 14px; padding: 10px; border: 1px s=
olid #979797;" align=3D"center" valign=3D"top">

an style=3D"font-size: 13px;">Submission Deadline

 ss=3D"dataTable_content-cell" style=3D"text-align: center; vertical-align: =
top; font-size: 14px; padding: 10px; border: 1px solid #979797;" align=3D"c=
enter" valign=3D"top">

px;">Jan.31

 "text-align: center; vertical-align: top; font-size: 14px; padding: 10px; b=
order: 1px solid #979797;" align=3D"center" valign=3D"top">

gin: 0;">Feb.4
cal-align: top; font-size: 14px; padding: 10px; border: 1px solid #979797;"=
align=3D"center" valign=3D"top">

nt-size: 13px;">Decision of Acceptance

 able_content-cell" style=3D"text-align: center; vertical-align: top; font-s=
ize: 14px; padding: 10px; border: 1px solid #979797;" align=3D"center" vali=
gn=3D"top">

May 1<=
/span>

 center; vertical-align: top; font-size: 14px; padding: 10px; border: 1px s=
olid #979797;" align=3D"center" valign=3D"top">

an style=3D"font-size: 13px;">April 29
lass=3D"dataTable_content-cell" style=3D"text-align: center; vertical-align=
: top; font-size: 14px; padding: 10px; border: 1px solid #979797;" align=3D=
"center" valign=3D"top">

13px;">Final Version Deadline

 ent-cell" style=3D"text-align: center; vertical-align: top; font-size: 14px=
; padding: 10px; border: 1px solid #979797;" align=3D"center" valign=3D"top=
">

May 15p>

vertical-align: top; font-size: 14px; padding: 10px; border: 1px solid #97=
9797;" align=3D"center" valign=3D"top">

=3D"font-size: 13px;">June 3
" style=3D"table-layout: fixed;" width=3D"100%" border=3D"0" cellpadding=3D=
"0" cellspacing=3D"0"> =
e=3D"" width=3D"100%" align=3D"center" valign=3D"top">
llpadding=3D"0" cellspacing=3D"0" style=3D"table-layout: fixed;">
class=3D"text_content-cell content-padding-horizontal" style=3D"text-align:=
left; font-family: Arial,Verdana,Helvetica,sans-serif; color: #2f2f2f; fon=
t-size: 16px; line-height: 1.2; display: block; word-wrap: break-word; padd=
ing: 10px 50px;" align=3D"left" valign=3D"top">

n style=3D"font-size: 13px;">*Contributions submitted to RA-L / BioRob will=
go through a separate process.
xed;" width=3D"100%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0"> =
table>
=3D"center" valign=3D"top">
border=3D"0">
al" style=3D"padding: 10px 50px;" width=3D"100%" align=3D"center" valign=3D=
"top"> 0%;" cellpadding=3D"0" cellspacing=3D"0" border=3D"0">
vider_content-cell" style=3D"height: 1px; line-height: 1px; padding-bottom:=
0px; background-color: #403F42; border-bottom-width: 0px;" height=3D"1" al=
ign=3D"center" bgcolor=3D"#403F42"> 3D""border=3D"0" hspace=3D"0" vspace=3D"0" src=3D"https://imgssl.constantcontac=
t.com/letters/images/1101116784221/S.gif" style=3D"display: block; height: =
1px; width: 5px;">
d;" width=3D"100%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0"> <=
td class=3D"column column--1 scale stack" style=3D"" width=3D"100%" align=
=3D"center" valign=3D"top">
cellpadding=3D"0" cellspacing=3D"0" border=3D"0">
Follow_container" width=3D"100%" align=3D"center" valign=3D"top" style=3D"p=
adding-top: 10px; padding-bottom: 10px; height: 1px; line-height: 1px;"> href=3D"https://r20.rs6.net/tn.jsp?f=3D001ZZriHBrpHq0Q9fqa4sFpOP2Bp_yL0bAj=
paX92MCohLagWY48_VLBA7srVKOEggyBjH4Ox80ixYR2YipZbZT8M6HdHecWeXXZLp6ucY049X-=
vhGRfBe3ItI4f79vz3x7xDr37EEyvGm7w0mr9wG1BkPqs7Lftmsdw&c=3DfsvHkqyFmkj6BCB4Y=
uRDh_97icrfTAzjK_IEoJV_CAbZRndzjrihXA=3D=3D&ch=3DfnlNFU0m1Qq2acsA15dIHfBzjO=
2FekgkD8tOgogsWiIXtbq-dgOXwg=3D=3D" data-trackable=3D"true">ocialFollow_icon" alt=3D"Facebook" width=3D"32" border=3D"0" src=3D"https:/=
/imgssl.constantcontact.com/letters/images/CPE/SocialIcons/circles/circleCo=
lor_Facebook.png" style=3D"display: inline-block; margin: 0; padding: 0;"><=
/a>  OP2Bp_yL0bAjpaX92MCohLagWY48_VLBA6HXzj2oHM9fcfIOm-aEWBE0n1Iet65uaQLNNOdx_Ro=
2JJdwEwwmoogv4vNL-yesAgmMTLvkKzJ_CZmgAMAilCXwoH7S_ijnsg=3D=3D&c=3DfsvHkqyFm=
kj6BCB4YuRDh_97icrfTAzjK_IEoJV_CAbZRndzjrihXA=3D=3D&ch=3DfnlNFU0m1Qq2acsA15=
dIHfBzjO2FekgkD8tOgogsWiIXtbq-dgOXwg=3D=3D" data-trackable=3D"true">ass=3D"socialFollow_icon" alt=3D"Twitter" width=3D"32" border=3D"0" src=3D"=
https://imgssl.constantcontact.com/letters/images/CPE/SocialIcons/circles/c=
ircleColor_Twitter.png" style=3D"display: inline-block; margin: 0; padding:=
0;">  qa4sFpOP2Bp_yL0bAjpaX92MCohLagWY48_VLBA8s64CAv9e3CZ84AvZ14eYRkJfbNnaAS2kYJR=
SNbercb1neteM72DLx7aQgdX4aTgpcbhcTUprTomWcS3PspQ71WMYGTlMjJd-Kg9h5KateQ&c=
=3DfsvHkqyFmkj6BCB4YuRDh_97icrfTAzjK_IEoJV_CAbZRndzjrihXA=3D=3D&ch=3DfnlNFU=
0m1Qq2acsA15dIHfBzjO2FekgkD8tOgogsWiIXtbq-dgOXwg=3D=3D" data-trackable=3D"t=
rue">3D"Instagram"=3D"0" src=3D"https://imgssl.constantcontact.com/letters/images/CPE/SocialI=
cons/circles/circleColor_Instagram.png" style=3D"display: inline-block; mar=
gin: 0; padding: 0;">  01ZZriHBrpHq0Q9fqa4sFpOP2Bp_yL0bAjpaX92MCohLagWY48_VLBAzdycEz6Z2qeWks1Z1YSK=
hMdvYk4a3014hZ7li6eCFiX2bu2E8BZOy3BluuLc0_dMkpx0cUWYeE5J54gNBALq4wJucl_E_hM=
lrFjpC-kgfpGBb-145xDVAI=3D&c=3DfsvHkqyFmkj6BCB4YuRDh_97icrfTAzjK_IEoJV_CAbZ=
RndzjrihXA=3D=3D&ch=3DfnlNFU0m1Qq2acsA15dIHfBzjO2FekgkD8tOgogsWiIXtbq-dgOXw=
g=3D=3D" data-trackable=3D"true">3D"Li=<BRnkedIn" width=3D"32" border=3D"0" src=3D"https://imgssl.constantcontact.com=
/letters/images/CPE/SocialIcons/circles/circleColor_LinkedIn.png" style=3D"=
display: inline-block; margin: 0; padding: 0;">  //r20.rs6.net/tn.jsp?f=3D001ZZriHBrpHq0Q9fqa4sFpOP2Bp_yL0bAjpaX92MCohLagWY4=
8_VLBAzdycEz6Z2qefeRTDgvfOHZKB-W4ab54oWEOAIZuiWiRl4c75HrN6qaOH8no9PcDxjFfpP=
LbsiMC4lx1X88OLh7zE84vLGhcgxl7Xq4QYoh6I6s-umEjhpw=3D&c=3DfsvHkqyFmkj6BCB4Yu=
RDh_97icrfTAzjK_IEoJV_CAbZRndzjrihXA=3D=3D&ch=3DfnlNFU0m1Qq2acsA15dIHfBzjO2=
FekgkD8tOgogsWiIXtbq-dgOXwg=3D=3D" data-trackable=3D"true">cialFollow_icon" alt=3D"YouTube" width=3D"32" border=3D"0" src=3D"https://i=
mgssl.constantcontact.com/letters/images/CPE/SocialIcons/circles/circleColo=
r_YouTube.png" style=3D"display: inline-block; margin: 0; padding: 0;">=
ell--systemFooter" style=3D"" align=3D"center" valign=3D"top"> s=3D"shell_width-row scale" style=3D"width: 100%;" align=3D"center" border=
=3D"0" cellpadding=3D"0" cellspacing=3D"0">
ell" style=3D"padding: 0px;" align=3D"center" valign=3D"top"> ss=3D"shell_content-row" width=3D"100%" align=3D"center" border=3D"0" cellp=
adding=3D"0" cellspacing=3D"0">
=3D"background-color: #ffffff; padding: 0;" align=3D"center" valign=3D"top"=
bgcolor=3D"#ffffff"> le-layout: fixed;" width=3D"100%" border=3D"0" cellpadding=3D"0" cellspacin=
g=3D"0">
=3D"100%" align=3D"center" valign=3D"top"> "100%" border=3D"0" cellpadding=3D"0" cellspacing=3D"0" style=3D"font-famil=
y: Verdana,Geneva,sans-serif; color: #5d5d5d; font-size: 12px;">
lass=3D"footer_container" align=3D"center"> r" width=3D"100%" cellpadding=3D"0" cellspacing=3D"0" border=3D"0" style=3D=
"background-color: #ffffff; margin-left: auto; margin-right: auto; table-la=
yout: auto !important;" bgcolor=3D"#ffffff">




auto; margin-right: auto; max-width: 100%;">




g: 16px 0px;">
lpadding=3D"0" cellspacing=3D"0">









5d5d5d; font-family: Verdana,Geneva,sans-serif; font-size: 12px; padding: 4=
px 0px;">
IEEE Engineering in Medicine and Biology Soci=
ety | ter-column">445 Hoes Lane, an>n>Piscataway, NJ 08854ooter-column">
10px 0px;">










5d5d5d; font-family: Verdana,Geneva,sans-serif; font-size: 12px; padding: 4=
px 0px;">
_HxeUABc47Q%3D&ch=3Dcfd83e20-b05d-11e4-8806-d4ae529a8250&ca=3D73b2a25c-f182=
-48fa-b528-cbc0b1894666" style=3D"color: #5d5d5d;">Unsubscribe ruben-at-mrbrkl=
yn.com
5d5d5d; font-family: Verdana,Geneva,sans-serif; font-size: 12px; padding: 4=
px 0px;">
_HxeUABc47Q%3D&ch=3Dcfd83e20-b05d-11e4-8806-d4ae529a8250&ca=3D73b2a25c-f182=
-48fa-b528-cbc0b1894666" style=3D"color: #5d5d5d;">Update Profile |
egal/about-constant-contact" style=3D"color: #5d5d5d;">About Constant Conta=
ct
5d5d5d; font-family: Verdana,Geneva,sans-serif; font-size: 12px; padding: 4=
px 0px;">
Sent by
n: none;">noreply-at-embs.org
in collaboration with

5d5d5d; font-family: Verdana,Geneva,sans-serif; font-size: 12px; padding: 4=
px 0px;">








&pn=3DROVING&nav=3D73b2a25c-f182-48fa-b528-cbc0b1894666" style=3D"color: #5=
d5d5d; text-decoration: none;">
3D"Trusted=3D"211" border=3D"0" hspace=3D"0" vspace=3D"0" src=3D"https://imgssl.const=
antcontact.com/ui/images1/logo_ctct_2x.png">
r: #5d5d5d; font-family: Verdana,Geneva,sans-serif; font-size: 9px;">
&pn=3DROVING&nav=3D73b2a25c-f182-48fa-b528-cbc0b1894666" style=3D"color: #5=
d5d5d; text-decoration: none;">Try email marketing for free today!
=


------=_Part_62521646_1555497516.1641502883708--

--===============1742927418==
Content-Type: text/plain; charset="us-ascii"
MIME-Version: 1.0
Content-Transfer-Encoding: 7bit
Content-Disposition: inline

_______________________________________________
Hangout mailing list
Hangout-at-nylxs.com
http://lists.mrbrklyn.com/mailman/listinfo/hangout

--===============1742927418==--

  1. 2022-01-01 From: "Greg Farough, FSF" <info-at-fsf.org> Subject: [Hangout - NYLXS] Help keep the end-of-year momentum going:
  2. 2022-01-02 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Taking the eye off the ball
  3. 2022-01-03 G?bor Szab? <gabor-at-szabgab.com> Subject: [Hangout - NYLXS] [Perlweekly] #545 - Happy, Healthy,
  4. 2022-01-04 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Fwd: This is How They Really Talk About Israel
  5. 2022-01-04 From: "Free Software Foundation" <info-at-fsf.org> Subject: [Hangout - NYLXS] Free Software Supporter Issue 165, January 2022
  6. 2022-01-06 IEEE Engineering in Medicine and Biology Society <noreply-at-embs.org> Subject: [Hangout - NYLXS] Call for Papers - 9th IEEE RAS/EMBS International
  7. 2022-01-06 raf <postfix-at-raf.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  8. 2022-01-05 raf <postfix-at-raf.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  9. 2022-01-06 Viktor Dukhovni <postfix-users-at-dukhovni.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  10. 2022-01-03 raf <postfix-at-raf.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  11. 2022-01-05 Viktor Dukhovni <postfix-users-at-dukhovni.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  12. 2022-01-05 Viktor Dukhovni <postfix-users-at-dukhovni.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  13. 2022-01-05 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  14. 2022-01-03 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  15. 2022-01-08 Alain Knaff via info-gnu <info-gnu-at-gnu.org> Subject: [Hangout - NYLXS] GNU mtools 4.0.37 released
  16. 2022-01-09 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Aaron Swartz
  17. 2022-01-09 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Rutstein DMCA lawsuite
  18. 2022-01-09 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] More on the Rutstien DMCA copyright suite
  19. 2022-01-09 Alexandre Oliva <lxoliva-at-fsfla.org> Subject: [Hangout - NYLXS] GNU Linux-libre 5.16-gnu
  20. 2022-01-10 G?bor Szab? <gabor-at-szabgab.com> Subject: [Hangout - NYLXS] [Perlweekly] #546 - Perl Books
  21. 2022-01-10 Alex <mysqlstudent-at-gmail.com> Subject: [Hangout - NYLXS] TLS ciphers
  22. 2022-01-10 Alex <mysqlstudent-at-gmail.com> Re: [Hangout - NYLXS] TLS ciphers
  23. 2022-01-10 From: "Medscape News Alert" <Medscape_News_Alert-at-mail.medscape.com> Subject: [Hangout - NYLXS] FDA OKs New Adult Insomnia Med
  24. 2022-01-11 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] One Man, One Vote..
  25. 2022-01-11 From: "Shaina Taub" <shainataub-at-e.atlanticrecords.com> Subject: [Hangout - NYLXS] 'Songs of the Great Hill'
  26. 2022-01-12 Luis Falcon <falcon-at-gnuhealth.org> Re: [Hangout - NYLXS] [Health] Renaming openSUSE repositories for
  27. 2022-01-12 Luis Falcon <falcon-at-gnuhealth.org> Re: [Hangout - NYLXS] [Health] MyGNUHealth Flatpak
  28. 2022-01-11 Alessio <alciregi-at-posteo.net> Subject: [Hangout - NYLXS] [Health] MyGNUHealth Flatpak
  29. 2022-01-12 Axel Braun <axel.braun-at-gmx.de> Subject: [Hangout - NYLXS] [Health] Renaming openSUSE repositories for GNU
  30. 2022-01-12 Axel Braun <axel.braun-at-gmx.de> Re: [Hangout - NYLXS] [Health] MyGNUHealth Flatpak
  31. 2022-01-14 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] what vaccines mean to business
  32. 2022-01-15 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Anti-Semetism in the coin business?
  33. 2022-01-15 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] You really need to see what can be done without a
  34. 2022-01-14 From: "Greg Farough, FSF" <info-at-fsf.org> Subject: [Hangout - NYLXS] Share your free software journey and help others
  35. 2022-01-15 Alessio <alciregi-at-posteo.net> Re: [Hangout - NYLXS] [Health] desktop and metainfo files
  36. 2022-01-15 From: "Medscape CME & Education" <Medscape-at-mail.medscape.org> Subject: [Hangout - NYLXS] Help Improve The Lives of Those Living With HIV
  37. 2022-01-14 Luis Falcon <falcon-at-gnuhealth.org> Re: [Hangout - NYLXS] [Health] desktop and metainfo files
  38. 2022-01-14 Alessio <alciregi-at-posteo.net> Subject: [Hangout - NYLXS] [Health] desktop and metainfo files
  39. 2022-01-14 Luis Falcon <falcon-at-gnuhealth.org> Re: [Hangout - NYLXS] [Health] Renaming openSUSE repositories for
  40. 2022-01-14 Axel Braun <axel.braun-at-gnuhealth.org> Re: [Hangout - NYLXS] [Health] Renaming openSUSE repositories for
  41. 2022-01-17 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Faucci and his critics
  42. 2022-01-17 G?bor Szab? <gabor-at-szabgab.com> Subject: [Hangout - NYLXS] [Perlweekly] #547 - Learning a human language vs.
  43. 2022-01-17 Luis Falcon <falcon-at-gnuhealth.org> Re: [Hangout - NYLXS] [Health] desktop and metainfo files
  44. 2022-01-17 Alessio <alciregi-at-posteo.net> Re: [Hangout - NYLXS] [Health] desktop and metainfo files
  45. 2022-01-17 Luis Falcon <falcon-at-gnuhealth.org> Re: [Hangout - NYLXS] [Health] desktop and metainfo files
  46. 2022-01-17 Luis Falcon <falcon-at-gnuhealth.org> Re: [Hangout - NYLXS] [Health] desktop and metainfo files
  47. 2022-01-18 Alessio <alciregi-at-posteo.net> Re: [Hangout - NYLXS] [Health] desktop and metainfo files
  48. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  49. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  50. 2022-01-18 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  51. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  52. 2022-01-18 Matus UHLAR - fantomas <uhlar-at-fantomas.sk> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  53. 2022-01-18 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  54. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  55. 2022-01-18 Chris Green <cl-at-isbd.net> Re: [Hangout - NYLXS] Adding a second line to .forward,
  56. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  57. 2022-01-18 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  58. 2022-01-12 Bill Cole <postfixlists-070913-at-billmail.scconsult.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  59. 2022-01-18 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding a second line to .forward,
  60. 2022-01-12 Bill Cole <postfixlists-070913-at-billmail.scconsult.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  61. 2022-01-12 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  62. 2022-01-12 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  63. 2022-01-12 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  64. 2022-01-11 raf <postfix-at-raf.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  65. 2022-01-11 Phil Biggs <mb170712-at-pjb.cc> Subject: [Hangout - NYLXS] Virtual users with postfix and dovecot
  66. 2022-01-11 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  67. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  68. 2022-01-18 Matus UHLAR - fantomas <uhlar-at-fantomas.sk> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  69. 2022-01-18 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  70. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  71. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  72. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  73. 2022-01-18 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  74. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  75. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  76. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  77. 2022-01-18 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  78. 2022-01-11 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  79. 2022-01-12 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  80. 2022-01-11 Bill Cole <postfixlists-070913-at-billmail.scconsult.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  81. 2022-01-11 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  82. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  83. 2022-01-18 Chris Green <cl-at-isbd.net> Re: [Hangout - NYLXS] Adding a second line to .forward,
  84. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  85. 2022-01-18 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  86. 2022-01-11 Phil Biggs <mb170712-at-pjb.cc> Subject: [Hangout - NYLXS] Virtual users with postfix and dovecot
  87. 2022-01-18 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  88. 2022-01-12 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  89. 2022-01-18 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding a second line to .forward,
  90. 2022-01-12 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  91. 2022-01-11 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  92. 2022-01-12 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  93. 2022-01-11 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  94. 2022-01-06 Viktor Dukhovni <postfix-users-at-dukhovni.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  95. 2022-01-11 raf <postfix-at-raf.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  96. 2022-01-06 raf <postfix-at-raf.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  97. 2022-01-05 raf <postfix-at-raf.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  98. 2022-01-05 Viktor Dukhovni <postfix-users-at-dukhovni.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  99. 2022-01-05 Viktor Dukhovni <postfix-users-at-dukhovni.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  100. 2022-01-12 Bill Cole <postfixlists-070913-at-billmail.scconsult.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  101. 2022-01-12 Bill Cole <postfixlists-070913-at-billmail.scconsult.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  102. 2022-01-11 Bill Cole <postfixlists-070913-at-billmail.scconsult.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  103. 2022-01-11 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  104. 2022-01-12 Wietse Venema <wietse-at-porcupine.org> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  105. 2022-01-11 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  106. 2022-01-05 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  107. 2022-01-18 Matus UHLAR - fantomas <uhlar-at-fantomas.sk> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  108. 2022-01-18 From: "Joe Acquisto-j4" <joea-at-j4computers.com> Re: [Hangout - NYLXS] SASL questions
  109. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Adding Additional domains and outgoing email
  110. 2022-01-18 Paul Robert Marino <prmarino1-at-gmail.com> Subject: [Hangout - NYLXS] Fwd: SASL questions
  111. 2022-01-18 Ruben Safir <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] (fwd) de Blasio ruined New York City
  112. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Check this out. It doesn
  113. 2022-01-18 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Chofitz Chaim Auction needs some help...
  114. 2022-01-18 From: "Free Software Foundation" <info-at-fsf.org> Subject: [Hangout - NYLXS] FSF expands process for associate members to
  115. 2022-01-19 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] Check this out. It doesn
  116. 2022-01-20 aviva <aviva-at-gmx.us> Re: [Hangout - NYLXS] Check this out. It doesn
  117. 2022-01-20 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Check this out. It doesn
  118. 2022-01-19 From: "Free Software Foundation" <info-at-fsf.org> Subject: [Hangout - NYLXS] New year,
  119. 2022-01-24 G?bor Szab? <gabor-at-szabgab.com> Subject: [Hangout - NYLXS] [Perlweekly] #548 - Perl Books Collection
  120. 2022-01-25 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] The suppresion of desenting scientific opinions
  121. 2022-01-26 From: "Pat Schloss" <pschloss-at-umich.edu> Subject: [Hangout - NYLXS] [mothur] mothur v.1.47.0 release
  122. 2022-01-28 Ruben Safir <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] security and Free Software in the WSJ - eh
  123. 2022-01-29 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] New Zealand Lockdown
  124. 2022-01-30 Steve Hay <stevehay-at-apache.org> Subject: [Hangout - NYLXS] [ANNOUNCE] mod_perl-2.0.12
  125. 2022-01-02 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Embperl and threaded mpm?
  126. 2022-01-02 Neil Gunton <neil-at-nilspace.com> Re: [Hangout - NYLXS] Embperl and threaded mpm?
  127. 2022-01-02 Jim Tappe <jtappe-at-gmail.com> Re: [Hangout - NYLXS] Embperl and threaded mpm?

NYLXS are Do'ers and the first step of Doing is Joining! Join NYLXS and make a difference in your community today!